Ledger.Open graph →
SEC Form D · filed March 3, 2021

BioSplice Therapeutics, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gur Roshwalb · San Diego, CADirectorKaren Mcginnis · San Diego, CADirectorSusannah Gray · San Diego, CADirectorOsman Kibar · San Diego, CAExec · DirectorJeremy Wilson · Rogers, ARExec · DirectorChristopher T. Ladd · Rogers, ARDirectorBrendan W. Lake · Conshohocken, PADirectorNewRoad Fund IV GP, L.P · Rogers, ARDirectorCevdet Samikoglu · Purchase, NYDirectorJoy Ghosh · New Jersey, NJDirectorArman Oruc · San Diego, CAExecWalter W. Buckley Iii · Chester Springs, PADirectorKirby Winfield · Seattle, WADirectorJoanna L. Lohkamp · Los Angeles, CADirectorSandi S. Bragar · Los Angeles, CAExec · DirectorCevdet Samikoglu · San Diego, CADirectorJoy Ghosh · CAMBRIDGE, MADirectorArman Oruc · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗